Bison Wealth, LLC Novartis Ag Transaction History

Bison Wealth, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 16, 2020	SELL	$82.14 - $91.0 $215,453 - $238,693	-2,623 Closed	0 $0
Q2 2020 Aug 03, 2020	SELL	$80.93 - $91.1 $13,353 - $15,031	-165 Reduced 5.92%	2,623 $229,000
Q1 2020 May 04, 2020	SELL	$70.67 - $99.01 $4,946 - $6,930	-70 Reduced 2.45%	2,788 $230,000
Q3 2019 Nov 04, 2019	SELL	$85.54 - $94.26 $5,987 - $6,598	-70 Reduced 2.39%	2,858 $248,000
Q2 2019 Aug 05, 2019	SELL	$75.4 - $92.8 $6,032 - $7,424	-80 Reduced 2.66%	2,928 $267,000
Q4 2018 Feb 08, 2019	SELL	$73.66 - $82.02 $2,209 - $2,460	-30 Reduced 0.99%	3,008 $258,000
Q3 2018 Nov 09, 2018	BUY	$66.94 - $77.43 $669 - $774	10 Added 0.33%	3,038 $262,000
Q2 2018 Aug 09, 2018	SELL	$64.91 - $73.36 $11,683 - $13,204	-180 Reduced 5.61%	3,028 $229,000
Q1 2018 May 08, 2018	BUY	$70.39 - $84.15 $12,670 - $15,147	180 Added 5.94%	3,208 $259,000
Q3 2017 Oct 27, 2017	BUY	$74.14 - $77.27 $224,495 - $233,973	3,028	3,028 $260,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Bison Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Bison Wealth, LLC with notifications on news.